Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The global polymyalgia rheumatica treatment market attained a value of about USD 203.73 Million in 2024. The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 4.70% to reach nearly USD 322.49 Million by 2034.

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Compound Annual Growth Rate

Value in USD Million

4.7%

2025-2034


Polymyalgia Rheumatica Treatment Market Outlook

*this image is indicative*

Extensive Use of Medications in the Treatment of Polymyalgia Rheumatica Boosting the Market Growth

Polymyalgia is usually treated with medications such as corticosteroids to ease symptoms and uneasiness. Steroids are one of the most common drugs for polymyalgia rheumatica treatment. It can ease pain and stiffness in a few days. However, the use of the drug requires extensive monitoring as it can lead to serious side effects, such as loss of bone density, cataracts, and high blood pressure. This leads to routine diagnostic tests to monitor the effect and treatment of the disease, hence augmenting the industry growth. Moreover, the growing demand for immune suppressing medications such as methotrexate in the early course of treatment is significantly contributing to the market growth.

Global Polymyalgia Rheumatica Treatment Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

In addition, the development of drugs that can treat various rheumatological diseases, such as polymyalgia rheumatica and rheumatoid arthritis, is propelling the market growth. This is expected to surge its demand among people with several health-related issues, to significantly contribute to the market growth. Moreover, the introduction of clinical programs by leading companies to evaluate the safety and efficiency of novel drugs is invigorating the growth of the polymyalgia rheumatica treatment industry.

Polymyalgia Rheumatica Treatment: Market Segmentation

Polymyalgia rheumatica treatment is the treatment of the inflammatory disorder that causes stiffness, muscle pain, and inflammation in the hips and shoulders. It is usually prevalent among the geriatric population, especially women. It is treated by using corticosteroids, methotrexate, and vitamin D supplements.

The major diagnostic methods of polymyalgia rheumatica treatment are

  • Blood Tests
  • Imaging Tests

The market can be broadly categorised on the basis of its drug class into

  • Corticosteroids
  • Disease-Modifying Anti-Rheumatic Drugs
  • Non-steroidal Anti-Inflammatory Drugs
  • Others

Based on route of administration, the market is divided into

  • Oral
  • Parenteral

By end use, the market is classified into

  • Hospitals
  • Homecare
  • Speciality Clinics
  • Others

Market breakup by region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Rising Deployment of Advanced Diagnostic Technology to Augment the Polymyalgia Rheumatica Treatment Industry

Increasing research on polymyalgia rheumatica to study its association with musculoskeletal symptoms is expected to augment the market growth. The deployment of advanced diagnostic technologies to analyse subacromial and subdeltoid bursitis of shoulders, hip synovitis, and iliopectineal bursitis, to develop their effective treatment is projected to propel the industry growth. Moreover, technological advancements in imaging tests such as magnetic resonance imaging (MRI) are minimising its scorer bias to diagnose the disease effectively. As MRI can detect asymptomatic cases of polymyalgia rheumatica, it is surging the demand for its treatment, which is consequently accelerating the market growth of polymyalgia rheumatica treatment.

As physical therapy does not result in side effects, its popularity is significantly growing. This is increasing the demand for physiotherapy in the treatment of polymyalgia rheumatica, which is propelling the industry growth. Physiotherapies are customised based on the severity of diseases to provide a personalised treatment of the disease, due to which it is increasingly being adopted. Physiotherapy can aid in enhancing cardiovascular levels, reducing stiffness, improving mobility, and increasing muscle strength to allow patients to live at norm and ease, therefore significantly contributing to the market growth. Moreover, the rising availability of specific physiotherapy programs at hospitals and speciality clinics is surging their accessibility, which is providing further impetus to the growth of the polymyalgia rheumatica treatment industry.

Key Industry Players in the Global Polymyalgia Rheumatica Treatment Market

The report presents a detailed analysis of the following key players in the global polymyalgia rheumatica treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Sanofi SA
  • Apotex Corporation
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Horizon Therapeutics plc
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Our Top Selling Reports

India Disposable Medical Gloves Market

Global Aortic Valve Replacement Devices Market

Global JE (Japanese Encephalitis) Vaccine Market

South Africa Orthopaedic Braces and Supports Market

Health Economics and Outcomes Research (HEOR) Market

Picture Archiving and Communication System (PACS) Market

Contract Development and Manufacturing Organization (CDMO) Market

Latin America Advanced Wound Care Market

Global Implantable Medical Devices Market

Latin America In-vitro Diagnostics Market

Polymyalgia Rheumatica Treatment Market Report Snapshots

Polymyalgia Rheumatica Treatment Market Size

Polymyalgia Rheumatica Treatment Market Growth

Polymyalgia Rheumatica Treatment Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2024, the market attained a value of nearly USD 203.73 million.

The market is projected to grow at a CAGR of 4.70% between 2025 and 2034.

The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach around USD 322.49 Million by 2034.

The increasing demand for 3D CAD software in major industry verticals, the surging demand for enhanced design and virtual testing technology, and the growing investments in R&D activities are the major drivers of the market.

The key trends propelling the market include rising digitalisation and rapid technological advancements.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major diagnostic methods of polymyalgia rheumatica treatment in the market are blood tests and imaging tests.

The significant drug classes considered in the market report are corticosteroids, disease-modifying anti-rheumatic drugs, and non-steroidal anti-inflammatory drugs, among others.

Oral and parenteral are the different routes of administration for polymyalgia rheumatica treatment.

The various end uses of polymyalgia rheumatica treatment are hospitals, homecare, and speciality clinics, among others.

The major players in the market are Sanofi SA, Apotex Corporation, GlaxoSmithKline plc, AbbVie Inc., and Horizon Therapeutics plc, among others.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2024
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnostic Method
  • Drug Class
  • Route of Administration
  • End Use
  • Region
Breakup by Diagnostic Method
  • Blood Tests
  • Imaging Tests
Breakup by Drug Class
  • Corticosteroids
  • Disease-Modifying Anti-Rheumatic Drugs
  • Nonsteroidal Anti-Inflammatory Drugs
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
Breakup by End Use
  • Hospitals
  • Homecare
  • Speciality Clinics
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Sanofi SA
  • Apotex Corporation
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Horizon Therapeutics plc
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-723-689-1189

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-723-689-1189

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124